Clinical significance of microRNA-1180-3p for colorectal cancer and effect of its alteration on cell function

References

• Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164.
   PubMed Web of Science ®Google Scholar
• Cao M, Li H, Sun D, et al. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun (Lond). 2020;40(5):205–210.
   PubMed Web of Science ®Google Scholar
• Available from: https://gco.iarc.fr/today/online-analysis-multi-bars?v=2020&mode=cancer&mode_population=countries&population=900&populations=900&key=total&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17items=10&group_cancer=1&include_nmsc=1&include_nmsc_other=1&type_multiple=%257B%2522inc%2522%253Afalse%252C%2522mort%2522%253Atrue%252C%2522prev%2522%253Afalse%257D&orientation=horizontal&type_sort=0&type_nb_items=%257B%2522top%2522%253Atrue%252C%2522bottom%2522%253Afalse%257D
   Google Scholar
• Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019;394(10207):1467–1480.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zheng R, Zhang S, et al. Colorectal cancer burden and trends: comparison between China and major burden countries in the world. Chin J Cancer Res. 2021;33(1):1–10.
   PubMed Web of Science ®Google Scholar
• Bénard F, Barkun AN, Martel M, et al. Systematic review of colorectal cancer screening guidelines for average-risk adults: summarizing the current global recommendations. World J Gastroenterol. 2018;24(1):124–138.
   PubMed Web of Science ®Google Scholar
• Ladabaum U, Dominitz JA, Kahi C, et al. Strategies for colorectal cancer screening. Gastroenterology. 2020;158(2):418–432.
   PubMed Web of Science ®Google Scholar
• Ij JE, Tutein Nolthenius CJ, Kuipers EJ, et al. CT-Colonography vs. colonoscopy for detection of high-risk sessile serrated polyps. Am J Gastroenterol. 2016;111(4):516–522.
   PubMed Web of Science ®Google Scholar
• Simard J, Kamath S, Kircher S. Survivorship guidance for patients with colorectal cancer. Curr Treat Options Oncol. 2019;20(5):38.
   PubMed Web of Science ®Google Scholar
• Okugawa Y, Grady WM, Goel A. Epigenetic alterations in colorectal cancer: emerging biomarkers. Gastroenterology. 2015;149(5):1204–1225.e12.
   PubMed Web of Science ®Google Scholar
• Dorn GW 2nd., Marian AJ, Watkins H. The genomic architecture of sporadic heart failure. Circ Res. 2011;108(10):1270–1283.
   PubMed Web of Science ®Google Scholar
• Plati J, Bucur O, Khosravi-Far R. Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb). 2011;3(4):279–296.
   PubMed Web of Science ®Google Scholar
• Jia J, Yao P, Arif A, et al. Regulation and dysregulation of 3ʹUTR-mediated translational control. Curr Opin Genet Dev. 2013;23(1):29–34.
   PubMed Web of Science ®Google Scholar
• Eizuka M, Osakabe M, Sato A, et al. Dysregulation of microRNA expression during the progression of colorectal tumors. Pathol Int. 2020;70(9):633–643.
   PubMed Web of Science ®Google Scholar
• Hung YH, Sethupathy P. Important considerations for studies of circulating microRNAs in clinical samples. EBioMedicine. 2017;24:22–23.
   PubMed Web of Science ®Google Scholar
• Zanutto S, Ciniselli CM, Belfiore A, et al. Plasma miRNA-based signatures in CRC screening programs. Int J Cancer. 2020;146(4):1164–1173.
   PubMed Web of Science ®Google Scholar
• Cojocneanu R, Braicu C, Raduly L, et al. Plasma and tissue specific miRNA expression pattern and functional analysis associated to colorectal cancer patients. Cancers (Basel). 2020;12:4.
   Web of Science ®Google Scholar
• Wang X, Li L, Xiao W, et al. Plasma microRNA-1207-5p as a potential biomarker for diagnosis and prognosis of colorectal cancer. Clin Lab. 2020;66:9.
   Web of Science ®Google Scholar
• Cai L, Ye L, Hu X, et al. MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4. Bioengineered. 2021;12(1):440–449.
   PubMed Web of Science ®Google Scholar
• Zhang R, Guo C, Liu T, et al. MicroRNA miR-495 regulates the development of Hepatocellular carcinoma by targeting C1q/tumor necrosis factor-related protein-3 (CTRP3). Bioengineered. 2021;12(1):6902–6912.
   PubMed Web of Science ®Google Scholar
• Zhu XL, Ren LF, Wang HP, et al. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. World J Gastroenterol. 2019;25(13):1580–1591.
   PubMed Web of Science ®Google Scholar
• Gmerek L, Martyniak K, Horbacka K, et al. MicroRNA regulation in colorectal cancer tissue and serum. PLoS One. 2019;14(8):e0222013.
   PubMed Web of Science ®Google Scholar
• Obrocea FL, Sajin M, Marinescu EC, et al. Colorectal cancer and the 7th revision of the TNM staging system: review of changes and suggestions for uniform pathologic reporting. Rom J Morphol Embryol. 2011;52(2):537–544.
   PubMed Web of Science ®Google Scholar
• Wardi L, Alaaeddine N, Raad I, et al. Glucose restriction decreases telomerase activity and enhances its inhibitor response on breast cancer cells: possible extra-telomerase role of BIBR 1532. Cancer Cell Int. 2014;14:60.
   PubMed Web of Science ®Google Scholar
• Chen H, Gu B, Zhao X, et al. Circular RNA hsa_circ_0007364 increases cervical cancer progression through activating methionine adenosyltransferase II alpha (MAT2A) expression by restraining microRNA-101-5p. Bioengineered. 2020;11(1):1269–1279.
   PubMed Web of Science ®Google Scholar
• Ning L, Zhang M, Zhu Q, et al. miR-25-3p inhibition impairs tumorigenesis and invasion in gastric cancer cells in vitro and in vivo. Bioengineered. 2020;11(1):81–90.
   PubMed Web of Science ®Google Scholar
• Mattiuzzi C, Lippi G. Current cancer epidemiology. J Epidemiol Glob Health. 2019;9(4):217–222.
   PubMed Web of Science ®Google Scholar
• Gini A, Jansen EEL, Zielonke N, et al. Impact of colorectal cancer screening on cancer-specific mortality in Europe: a systematic review. Eur J Cancer. 2020;127:224–235.
   PubMed Web of Science ®Google Scholar
• Fabris L, Ceder Y, Chinnaiyan AM, et al. The potential of microRNAs as prostate cancer biomarkers. Eur Urol. 2016;70(2):312–322.
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhang X, Wang L, et al. The plasma exosomal miR-1180-3p serves as a novel potential diagnostic marker for cutaneous melanoma. Cancer Cell Int. 2021;21(1):487.
   PubMed Web of Science ®Google Scholar
• Pascut D, Cavalletto L, Pratama MY, et al. Serum miRNA are promising biomarkers for the detection of early hepatocellular carcinoma after treatment with direct-acting antivirals. Cancers (Basel). 2019;11:11.
   Web of Science ®Google Scholar
• Zhou Z, Zhou X, Jiang Y, et al. Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation. Sci Rep. 2020;10(1):11573.
   PubMed Web of Science ®Google Scholar
• Gu L, Zhang J, Shi M, et al. The effects of miRNA-1180 on suppression of pancreatic cancer. Am J Transl Res. 2017;9(6):2798–2806.
   PubMed Web of Science ®Google Scholar
• Ge Q, Wang C, Chen Z, et al. The suppressive effects of miR-1180-5p on the proliferation and tumorigenicity of bladder cancer cells. Histol Histopathol. 2017;32(1):77–86.
   PubMed Web of Science ®Google Scholar
• Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–1207.
   PubMed Web of Science ®Google Scholar
• Liu J, Li J, Ma Y, et al. MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer. Bioengineered. 2021;12(1):3240–3251.
   PubMed Web of Science ®Google Scholar
• Zhou ZH, Zhou XG, Zhou ZW, et al. [Integrated analysis of DNA methylation and gene expression profiles of hepatocellular carcinoma to construct miR-1180-3p relevant ceRNA regulatory network]. Zhonghua Gan Zang Bing Za Zhi. 2020;28(6):481–487.
   PubMedGoogle Scholar
• Wu Y, Xu Y. Integrated bioinformatics analysis of expression and gene regulation network of COL12A1 in colorectal cancer. Cancer Med. 2020;9(13):4743–4755.
   PubMed Web of Science ®Google Scholar